J.P. Morgan
Report published August 3, 2026
J.P. Morgan Portfolio Managers Monthly Report – August 2026
J.P. Morgan · August 3, 2026
This monthly report provides thematic equity research, key stock initiations (including SpaceX), sector views (Healthcare), and top short ideas for the North American market.
Read the remaining 4 pages
Finvaulta summarizes J.P. Morgan's analysis. Attribute opinions, forecasts, time-sensitive values, and chronology to the issuer and report date; do not treat this page as an independent verification or a current market-data source.
Key Takeaways
- 1.SpaceX was initiated with an Overweight rating and $225 price target, highlighted for its launch leadership, vertical integration, and AI-driven growth potential.
- 2.The firm reiterates an Overweight stance on Healthcare, citing durable growth, technology-like profitability, and attractive valuations despite sector underperformance.
- 3.IBM remains Overweight despite recent mainframe-driven preannouncement disappointment, with analysts viewing the risk as currently priced in.
Table of Contents
- Highlighted Stories
- Top Short Ideas
- Initiations
- Rating Changes
- U.S. Analyst Focus List
- Catalyst Watch
- Flagship Publications & Research Themes
Report data
Catalyst Watch
| Metric | Estimate | Context |
|---|---|---|
| Starship launches | 5,000 annual | SpaceX launch projections |
| Alphabet 2027 Capex | 378 USD Billion | Modeling increased capex for cloud/AI capacity |
Access the full report
And others from the leading tier 1 banks.
Free account: read previews and a daily allowance of full reports. Pro removes the daily limit.
Authors / Editors
Ken Goldman · Head of North America Equity Research